肝移植手术中的心肺骤停:经手术期间的β阻塞对肝硬化患者的影响
R C Vela Pascual1, J M Pérez Peña1, A Elvira Rodríguez1
1Hospital Universitario Gregorio Marañón, Madrid, Spain.
Revista espanola de anestesiologia y reanimacion
|January 25, 2025
概括
在肝移植 (LT) 期间的手术内心肺骤停 (CPA) 是严重的. 在接受β-阻断剂的患者中,在LT期间的一例CPA病例成功地用先进的心肺复苏和特定的抗药治疗.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 心脏病学 心脏病学
- 麻醉学 麻醉学
背景情况:
- 术内心肺骤停 (CPA) 复杂化了肝移植 (LT),发生在约5%的病例中.
- 在LT期间经历CPA的患者的生存率显著降低 (~50%).
- 重灌综合征是新肝阶段CPA的常见原因,但必须考虑其他病因.
相关概念视频
Heart Failure Drugs: β-Blockers
311
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
311
Adrenergic Antagonists: ɑ and β-Receptor Blockers
405
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
405


